Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ICK-Gyn: Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

NCT05914974 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05914974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05914974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ICK-Gyn: Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Recruiting
Start date
September 11, 2023
Completion date
April 30, 2035
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, gynecological malignancies, ovarian cancer, vulvar cancer